These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9401779)
1. Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus. Margineanu DG; Wülfert E Br J Pharmacol; 1997 Nov; 122(6):1146-50. PubMed ID: 9401779 [TBL] [Abstract][Full Text] [Related]
2. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Margineanu DG; Wülfert E Eur J Pharmacol; 1995 Nov; 286(3):321-5. PubMed ID: 8608796 [TBL] [Abstract][Full Text] [Related]
4. Differential paired-pulse effects of gabazine and bicuculline in rat hippocampal CA3 area. Margineanu DG; Wülfert E Brain Res Bull; 2000 Jan; 51(1):69-74. PubMed ID: 10654583 [TBL] [Abstract][Full Text] [Related]
5. Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Birnstiel S; Wülfert E; Beck SG Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):611-8. PubMed ID: 9402041 [TBL] [Abstract][Full Text] [Related]
6. Levetiracetam opposes the action of GABAA antagonists in hypothalamic neurones. Poulain P; Margineanu DG Neuropharmacology; 2002 Mar; 42(3):346-52. PubMed ID: 11897113 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats. Margineanu DG; Klitgaard H Eur J Pharmacol; 2003 Apr; 466(3):255-61. PubMed ID: 12694808 [TBL] [Abstract][Full Text] [Related]
8. Multi-neuronal recordings reveal a differential effect of thapsigargin on bicuculline- or gabazine-induced epileptiform excitability in rat hippocampal neuronal networks. Sokal DM; Mason R; Parker TL Neuropharmacology; 2000 Sep; 39(12):2408-17. PubMed ID: 10974325 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca²⁺ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER). Yan HD; Ishihara K; Seki T; Hanaya R; Kurisu K; Arita K; Serikawa T; Sasa M Brain Res Bull; 2013 Jan; 90():142-8. PubMed ID: 23107646 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Margineanu DG; Klitgaard H Pharmacol Res; 2000 Oct; 42(4):281-5. PubMed ID: 10987984 [TBL] [Abstract][Full Text] [Related]
11. Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons. Angehagen M; Margineanu DG; Ben-Menachem E; Rönnbäck L; Hansson E; Klitgaard H Neuroreport; 2003 Mar; 14(3):471-5. PubMed ID: 12634506 [TBL] [Abstract][Full Text] [Related]
12. Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slices. Niespodziany I; Klitgaard H; Margineanu DG Neuroreport; 2003 Jul; 14(9):1273-6. PubMed ID: 12824774 [TBL] [Abstract][Full Text] [Related]
13. Input-output dependence reveals the components of GABAergic modulation in rat hippocampal CA3 in vivo. Margineanu DG; Wülfert E Arch Physiol Biochem; 1995 Apr; 103(1):115-21. PubMed ID: 8574768 [TBL] [Abstract][Full Text] [Related]
14. Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization. Margineanu DG; Klitgaard H Neuropharmacology; 2004 Nov; 47(6):926-34. PubMed ID: 15527826 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Klitgaard H; Matagne A; Grimee R; Vanneste-Goemaere J; Margineanu DG Seizure; 2003 Mar; 12(2):92-100. PubMed ID: 12566232 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of iontophoretic application of the GABAA-antagonists bicuculline and gabazine on tone-evoked local field potentials in primary auditory cortex: interaction with ketamine anesthesia. Kurt S; Moeller CK; Jeschke M; Schulze H Brain Res; 2008 Jul; 1220():58-69. PubMed ID: 18022607 [TBL] [Abstract][Full Text] [Related]
17. Modulation of abnormal synaptic transmission in hippocampal CA3 neurons of spontaneously epileptic rats (SERs) by levetiracetam. Hanaya R; Kiura Y; Serikawa T; Kurisu K; Arita K; Sasa M Brain Res Bull; 2011 Nov; 86(5-6):334-9. PubMed ID: 21968023 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation. Wakita M; Kotani N; Kogure K; Akaike N J Pharmacol Exp Ther; 2014 Feb; 348(2):246-59. PubMed ID: 24259680 [TBL] [Abstract][Full Text] [Related]
19. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Pisani A; Bonsi P; Martella G; De Persis C; Costa C; Pisani F; Bernardi G; Calabresi P Epilepsia; 2004 Jul; 45(7):719-28. PubMed ID: 15230693 [TBL] [Abstract][Full Text] [Related]
20. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]